Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Evelyn del Socorro Goicochea Ríos, Irma Luz Yupari-Azabache, Nélida Milly Otiniano, Néstor Iván Gómez-Goicochea
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
europepmc
Confidence 96%
openalex
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cardiovascular risk awareness, exercise practices and metabolic outcomes among patients with diabetes mellitus in northern Nigeria: A cross-sectional, multicenter study.
10.4103/npmj.npmj_54_24 · 2024
Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020.
10.1001/jama.2023.2307 · 2023
Cardiovascular risk factors in diabetic patients with and without metabolic syndrome: a study based on the Rafsanjan cohort study.
10.1038/s41598-022-27208-5 · 2023
Prevention of cardiovascular diseases and diabetes: importance of a screening program for the early detection of risk conditions in a target population.
10.15167/2421-4248/jpmh2021.62.4.2360 · 2021
Cardiovascular and mortality events in type 2 diabetes cardiovascular outcomes trials: a systematic review with trend analysis.
10.1007/s00592-018-1253-5 · 2019
Enfermedades cardiovasculares.
Kept as external metadata until matched
American Diabetes Association Professional Practice Committee. 6. Glycemic targets: standards of Medical Care in diabetes—2022.
10.2337/dc22-s006 · 2022
The dietary inflammatory index, obesity, type 2 diabetes, and cardiovascular risk factors and diseases.
10.1111/obr.13349 · 2022
datacite
Confidence 0%
Guidelines for cardiovascular risk reduction in patients with type 2 diabetes: JACC guideline comparison.
10.1016/j.jacc.2022.02.046 · 2022
Primary prevention of cardiovascular disease in diabetes mellitus.
10.1016/j.jacc.2017.07.001 · 2017
Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease.
10.1016/j.kint.2022.06.008 · 2022
CO79 early change in proteinuria as a surrogate endpoint in studies of IgA nephropathy: An updated patient-level meta-analysis and discussion of appropriate methodology.
10.1016/j.jval.2025.09.181 · 2025
Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular.
10.1016/j.nefro.2018.04.004 · 2018
Sex beyond cardiovascular risk factors and clinical biomarkers of cardiovascular disease.
10.31083/j.rcm2301019 · 2022
Sex-specific associations of cardiovascular risk factors and biomarkers with incident heart failure.
10.1016/j.jacc.2020.07.044 · 2020
Screening cardiovascular risk factors of diabetes patients in the primary diabetes clinics.
10.1097/md.0000000000026722 · 2021
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.
10.1016/s0140-6736(15)01225-8 · 2016
Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors.
10.1001/jama.2020.21749 · 2020
American Diabetes Association Professional Practice Committee. 5. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in diabetes-2022.
10.2337/dc22-s005 · 2022
Cardiovascular risk and protective factors in adults with and without diabetes mellitus (Italy, 2016-19).
10.1093/eurpub/ckac037 · 2022
The STROBE guidelines.
10.4103/sja.sja_543_18 · 2019
Bioestadística aplicada en investigación clínica: conceptos básicos.
10.1016/j.rmclc.2018.12.002 · 2019
Lipoprotein(a) as a cardiovascular risk factor among patients with and without diabetes Mellitus: the Mass General Brigham Lp(a) Registry.
10.1186/s12933-024-02348-2 · 2024
Guía técnica para la valoración nutricional antropométrica de la persona adulta mayor.
2013
Pruebas de laboratorio en atención primaria (II).
10.1016/j.semerg.2010.12.003 · 2011
A new equation to estimate glomerular filtration rate.
10.7326/0003-4819-150-9-200905050-00006 · 2009
Nefroprotección clásica: inhibidores del sistema renina angiotensina aldosterona.
10.1016/j.semerg.2023.102018 · 2023
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study.
10.1111/dom.14180 · 2021
Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: time to overcome multifactorial therapeutic inertia?.
10.1111/dom.13243 · 2018
Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.
10.1056/nejmoa1800256 · 2018
Coexistencia de factores de riesgo cardiovascular en pacientes con diabetes y vasculopatía periférica.
10.1016/j.arteri.2016.07.002 · 2016
Conceptos actuales sobre el envejecimiento y la enfermedad cardiovascular.
10.1016/j.rccar.2015.12.006 · 2016
Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study.
10.1186/s40001-024-01802-x · 2024
Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes.
10.1016/j.metabol.2021.154838 · 2021
Una revisión basada en nuevas evidencias.
10.1016/j.semerg.2014.10.015 · 2015
World Health Organization (WHO).
Kept as external metadata until matched
10.37774/9789275125892
10.37774/9789275125892
Cardiovascular risk in newly diagnosed type 2 diabetes patients in India.
10.1371/journal.pone.0263619 · 2022
Prevalence of diabetes, epidemiological characteristics and vascular complications.
10.24875/acm.21000410 · 2023
Prevalence of hypoglycemia among a sample of sulfonylurea-treated patients with Type 2 diabetes mellitus in Argentina: The real-life effectiveness and care patterns of diabetes management (RECAP-DM) study.
10.1016/j.endinu.2018.05.014 · 2018
Cardiovascular risk factors in adults with type 2 diabetes mellitus.
10.5281/zenodo.19857658 · doi-reference
Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts.
10.2337/dc11-s222 · doi-reference
The vasculature in prediabetes.
10.1161/circresaha.118.311912 · doi-reference
Assessing cardiovascular risk in patients with diabetes: An update.
10.2174/1573403x15666191111123622 · doi-reference
Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association.
10.1016/j.pcad.2020.08.003 · doi-reference
Factors associated with medication adherence in older patients: A systematic review.
10.1002/agm2.12045 · doi-reference
Association between medication adherence to chronic diseases and shift-work schedules in the Korean working population.
10.1038/s41598-022-26618-9 · doi-reference
Management of cardiovascular risk in perimenopausal women with diabetes.
10.4093/dmj.2020.0262 · doi-reference
Prevalence of cardiovascular risk factors and their association with renal impairment in elderly patients with type 2 diabetes mellitus in a Nigerian tertiary hospital: a cross-sectional study.
10.11604/pamj.2022.42.233.35265 · doi-reference
Association of diabetes duration and the risk of cardiovascular disease assessed by QRISK3 and INTERHEART risk scores in type 2 diabetes patients.
10.4103/jdrntruhs.jdrntruhs_60_24 · doi-reference
10-year cardiovascular risk in patients with newly diagnosed type 2 diabetes mellitus.
10.1016/j.jacc.2023.08.015 · doi-reference
Cardiovascular risk factors and physical activity for the prevention of cardiovascular diseases in the elderly.
10.3390/ijerph19010207 · doi-reference
Aging and endothelin: determinants of disease.
10.1016/j.lfs.2014.09.009 · doi-reference
Endothelial sodium channels trigger endothelial salt sensitivity with aging.
10.1161/hypertensionaha.114.03348 · doi-reference
Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.
10.1371/journal.pone.0192895 · doi-reference
Pathophysiology and the cardiorenal connection in heart failure. Circulating hormones: biomarkers or mediators.
10.1016/j.cca.2014.10.027 · doi-reference
Cardiovascular disease in chronic kidney disease: Pathophysiological insights and therapeutic options.
10.1161/circulationaha.120.050686 · doi-reference
High triglyceride to HDL cholesterol ratio is associated with increased coronary heart disease among White but not Black adults.
10.1016/j.ajpc.2021.100198 · doi-reference
Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels.
10.2337/diacare.23.11.1679 · doi-reference
Índice TG/HDL para identificar a sujetos con síndrome metabólico en población mexicana.
10.24875/gmm.22000079 · doi-reference
Influence of lifestyle on incident cardiovascular disease and mortality in patients with diabetes mellitus.
10.1016/j.jacc.2018.04.027 · doi-reference
Management of dyslipidemia and atherosclerotic cardiovascular risk in prediabetes.
10.1016/j.diabres.2022.109980 · doi-reference
Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study.
10.2337/diacare.25.11.1909 · doi-reference
Fisiopatología renal y mecanismos farmacológicos de nefroprotección.
10.1016/j.semerg.2023.102021 · doi-reference
Factors associated with the development of chronic kidney disease in patients with arterial hypertension.
10.2147/ijnrd.s448986 · doi-reference
Associated factors for chronic kidney disease in patients with diabetes mellitus 2: Retrospective study.
10.2147/ijnrd.s489891 · doi-reference